The most common targeted therapy for non-small cell lung adenocarcinoma (NSCLC) is epidermal cell growth factor receptor inhibitor (EGFR). For example: Gefitinib and so on. However, some patients with good results will develop resistance to small-molecule targeted drug therapy after a p...

        Human emotions often affect the progression of the disease, especially for cancer.         Bad emotions and stress will not breed cancer, but they will make cancer grow faster.         Because these mental activities produce a lo...

On September 28, 2020, the State Intellectual Property Office granted Shenzhen Yishi Kangning Biotechnology Co., Ltd. (Yoshi Kangning) an invention patent involving the company's core technology. The name of the patent is: "A recombinant adeno-associated virus vector carrying tumor-t...

Adeno-associated virus (adeno-associated virus, AAV) belongs to the Parvoviridae family. Members of this family are small, non-enveloped, and icosahedral viruses. The diameter of the virus particle is between 20 and 26 nm, and it contains a linear single-stranded DNA genome with a size bet...

As the living standards of our people are improving, the incidence of prostate cancer is also on the rise. At present, cancer immunotherapy has become the fourth mode of treatment after surgery, chemotherapy and radiotherapy. Years of clinical treatment practice proved that ACTL targeted cell...